Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar-Apr;28(2):546-56.
doi: 10.1377/hlthaff.28.2.546.

Patients' perceptions of generic medications

William H Shrank  1 , Emily R Cox, Michael A Fischer, Jyotsna Mehta, Niteesh K Choudhry
Affiliations

Patients' perceptions of generic medications

William H Shrank et al. Health Aff (Millwood). 2009 Mar-Apr.

Abstract

Insurers and policymakers encourage the use of generic drugs to reduce costs, but generics remain underused. We conducted a national survey of commercially insured adults to evaluate their perceptions about generic drugs. Patients agreed that generics are less expensive and a better value than brand-name drugs, and are just as safe. However, although 56 percent reported that Americans should use more generics, only 37.6 percent prefer to take generics. We discuss perceptions about communicating with practitioners about generics, generic substitution, and policymakers' role in influencing generic use. These findings underscore the challenge that providers, insurers, and policymakers face in stimulating the cost-effective use of medications.

PubMed Disclaimer

References

    1. IMS Health. IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $;286.5 Billion,” Press Release (Plymouth Meeting, Penn.: IMS Health, 12 March 2008) H. Kohl and W.H. Shrank, “Increasing Generic Drug Use in Medicare Part D: The Role of Government,” Journal of the American Geriatrics Society 55, no. 7 ( 2007): 1106–1109; and E. Cox et al., “Use of Generic Therapeutic Substitution Can Save Billions in Drug Costs. Drug Benefit Trends. 2006;18(no 3):165–179. - PubMed
    1. IMS Health, “IMS Health Reports”; Jaeger K. A Message from Kathleen Jaeger: It Pays to Invest in Generics. Pharmacy Times. 2006 April
    1. Haas JS, et al. Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000. Annals of Internal Medicine. 2005;142(no 11):891–897. - PubMed
    1. Fischer MA, Avorn J. Economic Implications of Evidence-Based Prescribing for Hypertension: Can Better Care Cost Less? Journal of the American Medical Association. 2004;291(no 15):1850–1856. - PubMed
    1. Henry J. Kaiser Family Foundation and Health Research and Educational Trust, “Employer Health Benefits: 2004 Summary of Findings,” http://www.kff.org/insurance/7148/upload/2004-Employer-Health-Benefits-S... (accessed 10 December 2008); and J. Hoadley et al. An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans. 2006. Apr [accessed 10 December 2008]. http://www.kff.org/medicare/upload/7489.pdf.

Publication types